Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Tuesday, February 10, 2026 at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results. An audio webcast will be available live and archived for one year on the company's Investor Relations website at investors.cvshealth.com.
CVS (NYSE:CVS) announced a $2.6 million grant from the CVS Health Foundation to the American Diabetes Association to expand a maternal diabetes program into two additional New York City communities on Jan 14, 2026.
The expansion builds on 18 months of work that improved early gestational diabetes screening and care coordination for hundreds of patients at Wyckoff Heights Medical Center. Over the next three years the program will scale EMR dashboards, increase access to continuous glucose monitoring and medically tailored meals, deliver multilingual education, and track patients from pregnancy through postpartum to measure outcomes.
CVS Health (NYSE: CVS) will hold a conference call for fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 at 8:00 a.m. ET.
An audio webcast will be broadcast simultaneously on the company's Investor Relations website at investors.cvshealth.com and will be archived there for one year.
CVS (NYSE: CVS) announced that its board approved a quarterly dividend of $0.665 per share on common stock.
The dividend is payable on February 2, 2026 to holders of record as of January 22, 2026.
CVS (NYSE:CVS) announced on Dec 11, 2025 that it is offering the measles-mumps-rubella (MMR) vaccine to South Carolina residents amid the state's current measles outbreak. More than 200 CVS Pharmacy and MinuteClinic locations across South Carolina will provide MMR vaccinations for patients ages 3 and older; MinuteClinic also provides the recommended second dose for children ages 4–6.
The MMR vaccine may provide some protection if given within 72 hours of exposure. Walk-ins are accepted at pharmacies, but appointments are encouraged via CVS.com, the CVS Health app, or MinuteClinic.com. Pharmacy and clinic staff can help check insurance coverage and determine immunity status.
CVS Health (NYSE: CVS) updated 2025 guidance, provided 2026 guidance, and outlined a multi-year growth plan at its 2025 Investor Day on Dec 9, 2025. The company raised 2025 revenue guidance to at least $400.0B, raised adjusted operating income guidance to $14.22B–$14.39B, and confirmed 2025 cash flow from operations of $7.5B–$8.0B. CVS initiated 2026 guidance with revenue of at least $400.0B, adjusted operating income of $15.07B–$15.41B, adjusted EPS of $7.00–$7.20, and at least $10.0B cash flow from operations.
The company expects a mid‑teens adjusted EPS CAGR through 2028, announced an AI‑native open consumer engagement platform, and reiterated strategic focus across Aetna, CVS Caremark, CVS Pharmacy, and Health Care Delivery.
CVS (NYSE: CVS) released its inaugural National Economic Impact Report on Dec 5, 2025, saying its operations deliver an annual $474 billion economic impact across the U.S. and support 1.3 million jobs nationwide.
The report cites 300,000+ employees, approximately 9,000 retail pharmacy locations and >1,000 walk-in and primary care clinics, serving 185 million individuals and placing nearly 85% of Americans within 10 miles of a CVS pharmacy.
Other metrics include $58.6 billion in local, state and federal taxes, $239 million in community investments, and 84,000 volunteer hours. The report uses IMPLAN-based analysis by Parker Strategy Group.
Aetna (NYSE: CVS) announced December 4, 2025 updates that simplify prior authorization, expand clinical collaboration, and add AI capabilities to the Aetna Health app.
Key actions: effective November 2025 Aetna now bundles medical and pharmacy prior authorizations for certain conditions (examples: IVF, musculoskeletal bundles including X-rays, THA/TKA, specified meds and DME). The Aetna Clinical Collaboration (ACC) program is live in 17 hospitals and is projected to reduce 30-day readmissions and length of stay by 5% when fully implemented. As part of CVS Health's $20 billion multi-year digital investment, generative AI features have launched to an initial population and will expand in early 2026.
Cornerstone Community Development, together with Winterwood and CVS Health (NYSE: CVS), will host the Prichard Centennial Residential Reveal & Next-Phase Preview on December 4, 2025 at 1:30 p.m. in Huntington, WV.
The event showcases newly completed residential spaces inside the historic Prichard building and previews the next restoration phase. CVS Health has invested more than $17 million in the Prichard adaptive-reuse and has invested over $21 million in affordable housing across West Virginia, helping create or preserve 800+ affordable units.
CVS Health (NYSE: CVS) announced that its Board elected President and CEO David Joyner as Chair of the Board, effective January 1, 2026. Michael Mahoney will remain the Board's Lead Independent Director, and Roger Farah will continue to serve on the Board after stepping down from Executive Chair.
Joyner was named President and CEO in October 2024 and the Board cited his nearly 40 years of industry experience and a year of operational, financial and cultural improvements. The company noted its workforce of more than 300,000 colleagues and said the combined Chair and CEO structure aims to support execution of long-term strategy and stockholder value.
FAQ
What is the current stock price of Cvs Health (CVS)?
What is the market cap of Cvs Health (CVS)?
